Procter & Gamble Health Ltd (PGHL) is currently trading at 5,420.15 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Procter & Gamble Health Limited focuses on manufacturing and marketing pharmaceuticals and chemicals, specializing in consumer health products with a strong emphasis on vitamins and supplements. The company has demonstrated a consistent revenue growth trajectory, achieving a sales increase of 8% and profit growth of 27% over the last fiscal year, despite a challenging macroeconomic environment. Leveraging an Integrated Growth Strategy, the company excels in delivering product superiority across multiple vectors, enhancing its market position and consumer loyalty. There's a strong emphasis on broadening market reach, evidenced by increased product availability in e-commerce and rural areas, reinforcing its distribution model transformation. Procter & Gamble Health takes an active role in community health initiatives through its SEHAT CSR program, aiming to improve healthcare accessibility and preventive education among underserved communities.

Over the past 52 weeks, Procter & Gamble Health Ltd has traded between a low of ₹4,699.70 and a high of ₹6,955.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Procter & Gamble Health Ltd has a market capitalization of approximately 8,980.51. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Procter & Gamble Health Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 25.16 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 8,980.51 Cr, Procter & Gamble Health Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Procter & Gamble Health Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Procter & Gamble Health Ltd is 25.16. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Standalone net profit for Q1 FY27 was ₹96.15 crore, up 45% from ₹66.18 crore in Q1 FY26.

Procter & Gamble Health reported standalone net profit of ₹96.15 crore in Q1 FY27, up 45% from ₹66.18 crore in Q1 FY26.

Management cited sales of about ₹4,300 crore (flat year-on-year) and PAT of about ₹850 crore, while the audited summary cited sales of ₹4,290 crore and PAT of ₹857 crore for FY26.

Based on financial forecasts and market trends, the share price for Procter & Gamble Hygiene and Health Care is projected to reach a maximum target of ₹24,000 by the end of 2030, assuming continued operational performance.